... Tyrosine kinase inhibitors (TKIs) are a type of targeted therapy and are the most common CML treatment.Your hematology specialist may recommend a TKI such as nilotinib (sold as Danziten or Tasigna), imatinib (Gleevec), dasatinib (Sprycel), bosutinib (Bosulif), ponatinib (Iclusig), or asciminib (Scemblix).Side effects may include: Fatigue (tiredness ...
CML Treatment Side Effects: 5 Tips for Relief
... Tyrosine kinase inhibitors (TKIs) are a type of targeted therapy and are the most common CML treatment.Your hematology specialist may recommend a TKI such as nilotinib (sold as Danziten or Tasigna), imatinib (Gleevec), dasatinib (Sprycel), bosutinib (Bosulif), ponatinib (Iclusig), or asciminib (Scemblix).Side effects may include: Fatigue (tiredness ...
... It’s taken with food once daily.PonatinibPonatinib (Iclusig) was approved by the FDA in 2012 as a third-generation TKI to treat Ph-positive CML that’s resistant to at least two other TKIs. It can also be used in those with a T315I mutation. It’s not recommended for people with newly diagnosed CML. ...
... If other TKIs don’t work well, you may be prescribed ponatinib (Iclusig) or asciminib (Scemblix). ...
... Some approved TKIs, such as asciminib and ponatinib (Iclusig), may help treat certain types of CML, including CML that has stopped improving with other treatments.Meanwhile, new drugs are in clinical trials to see if they’re safe and effective against CML that no longer responds to current treatments. ...
4 Facts To Know: Latest Research on CML
... Some approved TKIs, such as asciminib and ponatinib (Iclusig), may help treat certain types of CML, including CML that has stopped improving with other treatments.Meanwhile, new drugs are in clinical trials to see if they’re safe and effective against CML that no longer responds to current treatments. ...
... Ponatinib (Iclusig) — Take with or without food. In one study, about 30 percent of people on TKI therapy had trouble taking their medications every day as prescribed. In 2024, the U.S. Food and Drug Administration (FDA) approved Danziten, a new version of nilotinib that doesn’t require fasting. ...
How Fasting Affects People Taking CML Treatment
... Ponatinib (Iclusig) — Take with or without food. In one study, about 30 percent of people on TKI therapy had trouble taking their medications every day as prescribed. In 2024, the U.S. Food and Drug Administration (FDA) approved Danziten, a new version of nilotinib that doesn’t require fasting. ...
... Other TKIs that your doctor may recommend include: Dasatinib (Sprycel) Nilotinib (Tasigna) Bosutinib (Bosulif) Ponatinib (Iclusig) Asciminib (Scemblix) ChemotherapyChemotherapy is the use of drugs to treat cancer by killing rapidly growing cancer cells. ...
Identifying and Managing CML Blast Crisis
... Other TKIs that your doctor may recommend include: Dasatinib (Sprycel) Nilotinib (Tasigna) Bosutinib (Bosulif) Ponatinib (Iclusig) Asciminib (Scemblix) ChemotherapyChemotherapy is the use of drugs to treat cancer by killing rapidly growing cancer cells. ...
... Food and Drug Administration to treat CML: Bosutinib (Bosulif) Dasatinib (Sprycel) Imatinib (Gleevec) Nilotinib (Danziten and Tasigna) Ponatinib (Iclusig) Because TKIs usually work so well, doctors don’t use other drugs as often. However, in some cases, another treatment option is needed. ...
Chronic Myeloid Leukemia (CML): An Overview
... Food and Drug Administration to treat CML: Bosutinib (Bosulif) Dasatinib (Sprycel) Imatinib (Gleevec) Nilotinib (Danziten and Tasigna) Ponatinib (Iclusig) Because TKIs usually work so well, doctors don’t use other drugs as often. However, in some cases, another treatment option is needed. ...
... Examples of TKIs include: Asciminib (Scemblix) Bosutinib (Bosulif) Dasatinib (Sprycel) Imatinib (Gleevec) Nilotinib (sold under brand names Tasigna and Danziten) Ponatinib (Iclusig) Common side effects of these medications include: Nausea and vomiting Diarrhea Fatigue or extreme tiredness Headache Skin rashes Fever Edema (swelling caused by fluid buildup ...
4 Facts About CML Therapy: Side Effects, Hidden Barriers, and More
... Examples of TKIs include: Asciminib (Scemblix) Bosutinib (Bosulif) Dasatinib (Sprycel) Imatinib (Gleevec) Nilotinib (sold under brand names Tasigna and Danziten) Ponatinib (Iclusig) Common side effects of these medications include: Nausea and vomiting Diarrhea Fatigue or extreme tiredness Headache Skin rashes Fever Edema (swelling caused by fluid buildup ...
... Food and Drug Administration has approved four TKIs that can be used right after being diagnosed with CML: Imatinib (Gleevec) Dasatinib (Sprycel) Bosutinib (Bosulif) Nilotinib (Tasigna) If these targeted therapies don’t work to control CML, ponatinib (Iclusig) may also be an option. ...
The Benefits of Targeted Therapy for Leukemia
... Food and Drug Administration has approved four TKIs that can be used right after being diagnosed with CML: Imatinib (Gleevec) Dasatinib (Sprycel) Bosutinib (Bosulif) Nilotinib (Tasigna) If these targeted therapies don’t work to control CML, ponatinib (Iclusig) may also be an option. ...
... Medications in this category include: Imatinib (Gleevec) Nilotinib (Tasigna) Dasatinib (Sprycel) Bosutinib (Bosulif) Ponatinib (Iclusig) Asciminib (Scemblix) After a person with CML begins treatment, doctors will perform blood and bone marrow tests every three to six months to make sure the TKIs are working. ...
Phases of Chronic Myeloid Leukemia: Chronic, Accelerated, Blast
... Medications in this category include: Imatinib (Gleevec) Nilotinib (Tasigna) Dasatinib (Sprycel) Bosutinib (Bosulif) Ponatinib (Iclusig) Asciminib (Scemblix) After a person with CML begins treatment, doctors will perform blood and bone marrow tests every three to six months to make sure the TKIs are working. ...
Join
Your Privacy Choices
